The impact of the heparin-induced thrombocytopenia (HIT) computerized alert on provider behaviors and patient outcomes

被引:18
作者
Austrian, Jonathan S. [1 ]
Adelman, Jason S. [2 ]
Reissman, Stan H. [2 ]
Cohen, Hillel W. [3 ]
Billett, Henny H. [2 ]
机构
[1] NYU, Dept Med, Langone Med Ctr, New York, NY 10010 USA
[2] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA
[3] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
关键词
PHYSICIAN ORDER ENTRY; 4TS SCORE; DIAGNOSIS; MANAGEMENT;
D O I
10.1136/amiajnl-2011-000138
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objective The aim of this study was to measure the effect of an electronic heparin-induced thrombocytopenia (HIT) alert on provider ordering behaviors and on patient outcomes. Materials and Methods A pop-up alert was created for providers when an individual's platelet values had decreased by 50% or to < 100000/mm(3) in the setting of recent heparin exposure. The authors retrospectively compared inpatients admitted between January 24, 2008 and August 24, 2008 to a control group admitted 1 year prior to the HIT alert. The primary outcome was a change in HIT antibody testing. Secondary outcomes included an assessment of incidence of HIT antibody positivity, percentage of patients started on a direct thrombin inhibitor (DTI), length of stay and overall mortality. Results There were 1006 and 1081 patients in the control and intervention groups, respectively. There was a 33% relative increase in HIT antibody test orders (p-0.01), and 33% more of these tests were ordered the first day after the criteria were met when a pop-up alert was given (p=0.03). Heparin was discontinued in 25% more patients in the alerted group (p=0.01), and more direct thrombin inhibitors were ordered for them (p=0.03). The number who tested HIT antibody-positive did not differ, however, between the two groups (p=0.99). The length of stay and mortality were similar in both groups. Conclusions The HIT alert significantly impacted provider behaviors. However, the alert did not result in more cases of HIT being detected or an improvement in overall mortality. Our findings do not support implementation of a computerized HIT alert.
引用
收藏
页码:783 / 788
页数:6
相关论文
共 29 条
[1]   Heparin induced thrombocytopenia: diagnosis and management update [J].
Ahmed, I. ;
Majeed, A. ;
Powell, R. .
POSTGRADUATE MEDICAL JOURNAL, 2007, 83 (983) :575-582
[2]  
[Anonymous], 2009, PROD INF ARG INJ
[3]   Effect of computerized physician order entry and a team intervention on prevention of serious medication errors [J].
Bates, DW ;
Leape, LL ;
Cullen, DJ ;
Laird, N ;
Petersen, LA ;
Teich, JM ;
Burdick, E ;
Hickey, M ;
Kleefield, S ;
Shea, B ;
Vander Vliet, M ;
Seger, DL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (15) :1311-1316
[4]   Ten commandments for effective clinical decision support: Making the practice of evidence-based medicine a reality [J].
Bates, DW ;
Kuperman, GJ ;
Wang, S ;
Gandhi, T ;
Kittler, A ;
Volk, L ;
Spurr, C ;
Khorasani, R ;
Tanasijevic, M ;
Middleton, B .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2003, 10 (06) :523-530
[5]  
Bernstein Liebhard and Lifshitz, HEP IND THROMB CONS
[6]   Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay [J].
Bryant, Adam ;
Low, Joyce ;
Austin, Steven ;
Joseph, Joanne E. .
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (05) :721-726
[7]   Heparin-induced thrombocytopenia [J].
Chong, BH .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) :1471-1478
[8]   Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism [J].
Creekmore, Freddy M. ;
Oderda, Gary M. ;
Pendleton, Robert C. ;
Brixner, Diana I. .
PHARMACOTHERAPY, 2006, 26 (10) :1438-1445
[9]  
de Maistre E, 2006, CAN J ANAESTH, V53, pS123
[10]   Bivalirudin use in carotid endarterectomy in a patient with heparin-induced thrombocytopenia [J].
Finks, SW .
ANNALS OF PHARMACOTHERAPY, 2006, 40 (02) :340-343